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Abstract
Objective: To describe common intraoperative and pathologic findings of atypical
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parathyroid tumors (APTs) and evaluate clinical outcomes in patients undergoing
parathyroidectomy.
Methods: In this multi-institutional retrospective case series, data were collected
from patients who underwent parathyroidectomy from 2000 to 2018 from three tertiary care institutions. APTs were defined according to the AJCC eighth edition
guidelines and retrospective chart review was performed to evaluate the incidence
of recurrent laryngeal nerve injury, recurrence of disease, and disease-specific
mortality.
Results: Twenty-eight patients were identified with a histopathologic diagnosis of
atypical tumor. Mean age was 56 years (range, 23–83) and 68% (19/28) were female.
All patients had an initial diagnosis of primary hyperparathyroidism with 21% (6/28)
exhibiting clinical loss of bone density and 32% (9/28) presenting with nephrolithiasis
or renal dysfunction. Intraoperatively, 29% (8/28) required thyroid lobectomy, 29%
(8/28) had gross adherence to adjacent structures and 46% (13/28) had RLN adherence. The most common pathologic finding was fibrosis 46% (13/28). Postoperative
complications include RLN paresis/paralysis in 14% (4/28) and hungry bone syndrome in 7% (2/28). No patients with a diagnosis of atypical tumor developed recurrent disease, however there was one patient that had persistent disease and
hypercalcemia that is being observed. There were 96% (27/28) patients alive at last
follow-up, with one death unrelated to disease.
Conclusion: Despite the new AJCC categorization of atypical tumors staged as Tis,
we observed no recurrence of disease after resection and no disease-specific mortality. However, patients with atypical tumors may be at increased risk for recurrent
laryngeal nerve injury and incomplete resection.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any
medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
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I N T RO DU CT I O N

tumors can help support accurate diagnoses and management in light
of the most recent AJCC staging guidelines.

Parathyroid tumors are a relatively homogeneous group of neoplasms
affecting between 0.1% and 0.3% of the population, most commonly
associated with unregulated production of parathyroid hormone
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M A T E R I A L S A N D M ET H O D S
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(PTH), resulting in primary hyperparathyroidism (PHPT). The majority
of these tumors are solitary adenomas (85%), followed by multiple

In this multi-institutional retrospective case series, data were collected

gland hyperplasia (10%–15%) and rarely, carcinomas or atypical para-

from patients who underwent parathyroidectomy from 2000 to 2018

thyroid tumors (APTs) (<1%).2,3

as identified through billing codes (CPT 60500) and searching pathol-

Classification of the latter group, specifically APTs, has historically

ogy records from three tertiary care institutions. From this set of

been controversial, due to their ambiguous characteristics both clinically

patients, all subjects with a histopathologic diagnosis of APT were

and histopathologically. However, in 2018, the American Joint Commit-

selected for inclusion. Demographic criteria (age, sex), date of surgery,

tee on Cancer (AJCC) released its eighth edition and added a “Tis” cate-

medical history, comorbid illnesses, laboratory values (i.e., calcium,

gory to the staging of parathyroid carcinomas, specifically describing

PTH, comprehensive renal panel), complications, and outcomes (recur-

“Tis” as an atypical parathyroid neoplasm with uncertain malignant

rence of disease and disease-specific mortality) were collected.

potential.4

Diagnosis of APT was defined by presence of >2 of the following

APTs were defined as not meeting criteria of carcinoma

gross or pathologic criteria according to Seethala et al.: intratumoral

(i.e., invasion, metastasis), but nonetheless contain some worrisome

fibrotic bands, trabecular growth, increased mitotic activity (>1 mito-

features that place them in between the benign and malignant catego-

sis/10 high power field), cytologic atypia, necrosis, or adherence to

ries. Such features include fibrous bands, mitotic figures, necrosis, tra-

surrounding tissues intraoperatively, but not reaching the threshold

becular growth, or adherence to surrounding tissues intraoperatively,

for carcinoma (invasive growth into surrounding tissues, atypical

but these APTs are usually smaller and less likely to have coagulative

mitotic figures, lymphovascular invasion) (Figure 1).5 Retrospective

tumor necrosis than a true carcinoma.

4

chart review was performed to evaluate the incidence of recurrent

Given the recent clarification from the AJCC staging guidelines,

laryngeal nerve injury, recurrence of disease, and disease-specific

this study aims to evaluate immediate and long-term clinical

mortality. Recurrent laryngeal nerve injury was defined as known

outcomes—specifically, recurrent laryngeal nerve injury and recur-

injury during surgery as described by the operative report and/or

rence of disease—in patients undergoing parathyroidectomy for PHPT

evidence of hypomobility or immobility on postoperative clinical lar-

who were then discovered to have APT. Anecdotally, these APTs have

yngoscopy. Disease recurrence was defined as recurrent hypercalce-

been observed clinically for years, yet few studies have examined the

mia with high serum PTH levels, after a disease-free period

clinical presentation and behavior of these tumors. There is a paucity

(normocalcemia) of at least 6 months. Descriptive statistics were

of information regarding the clinical outcomes (e.g., morbidity and

used for demographic information. This study complied with institu-

mortality) and surveillance management of these patients. Increasing

tional review board protocols regarding privacy of patient data at

awareness among endocrine surgeons and pathologists of these

each respective institution.

Atypical Parathyroid Adenoma Pathologic Criteria
(Adapted from Seethala et. al5)
Presence of >2 of the following features:
Intratumoral fibrotic bands
Trabecular growth
Increased mitotic activity (>1 mitosis/10 HPF)
Necrosis
Cytologic atypia
Gross adherence to surrounding tissues intraoperatively
Does not reach threshold for carcinoma (regional invasive growth, atypical mitotic figures,
lymph-vascular invasion)

F I G U R E 1 Adapted from Seethala et al.5:
pathologic criteria for atypical parathyroid
adenoma.
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RESULTS

|

structures, and 46% (13/28) had RLN adherence. The most common
pathologic finding was fibrosis, 46% (13/28) (Table 2 and Figure 3).

3.1

|

Demographics and preoperative findings

This retrospective case series identified 29 patients with an initial histo-

3.3

Follow-up

|

pathologic diagnosis of APT. One patient was identified with a histopathologic diagnosis of parathyroid carcinoma in a separate gland 14 years after

After parathyroidectomy, postoperative complications included RLN

initial surgery and was excluded from analysis of APTs. Mean age was

paresis/paralysis 14% (4/28) and hungry bone syndrome 7% (2/28),

55.7 years (range, 23–83) and 68% (n = 19) were female. All patients had

but no patients with a diagnosis of atypical tumor developed recurrent

an initial diagnosis of PHPT with 21% (6/28) exhibiting clinical loss of bone

tumor at the same site after a follow-up time of mean 26.3 months

density and 32% (9/28) presenting with nephrolithiasis or renal dysfunc-

(SD 30.7) (Table 3). There was one patient that had persistent disease

tion (Table 1). Preoperative imaging (ultrasound, computed tomography,

and hypercalcemia that is being observed, believed to have had multi-

and/or nuclear medicine sestamibi localization) was obtained for patients

gland hyperplasia. The patient diagnosed with parathyroid carcinoma

per standard of care prior to surgery. Representative imaging from selected

in a separate gland on subsequent surgery did not experience any

patients with proven pathologic atypical tumors are shown in Figure 2.

RLN injury or postoperative complications. There were 27 of
28 patients alive at last follow-up, with one death unrelated to
disease.

3.2

|

Intraoperative findings

Intraoperatively, 29% (8/28) of patients also underwent a thyroid lobec-

4
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tomy, 29% (8/28) had evidence of APT gross adherence to adjacent
Given the most recent AJCC categorization of APTs as “Tis,” this
study aimed to evaluate the frequency of RLN injury and tumor recurrence in patients undergoing parathyroidectomy later determined to
TABLE 1

Demographics and preoperative clinical findings.

have an APT. In this study, we observed no recurrence of tumor after

n

%

9

32

resection and no disease-specific mortality. However, we did observe

Sex
Male

19

68

Diagnosis of primary hyperparathyroidism

Female

28

100

Clinical loss of bone density

6

21

Nephrolithiasis or renal dysfunction

9

32

Mean age at date of operation [years
(range)]

55.7 (23–83)

Mean follow-up [months; SD]

26.3; 30.7

TABLE 2

Postoperative histopathologic findings.

Thyroid lobectomy

n

%

8

29

Gross adherence

8

29

Recurrent laryngeal nerve adherence

13

46

Fibrosis on histopathology

13

46

F I G U R E 2 Representative imaging findings of atypical parathyroid adenoma. (A) Ultrasound of an atypical parathyroid adenoma
demonstrating a hypoechoic lesion with hyperechoic and cystic foci inferior to the left lobe of the thyroid. (B and C) Coronal and axial CT of an
atypical parathyroid adenoma demonstrating an isodense lesion with hyperdense foci posterior to the right lobe of the thyroid.
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F I G U R E 3 Representative slides of hematoxylin and eosin stains of pathologic features of atypical parathyroid adenomas. (A) Pattern
revealing prominent fibrous bands and trabecular pattern of growth (40). (B) Cytologic atypia, focal necrosis, and mitotic activity (200).
(C) Intracapsular growth of atypical parathyroid adenoma (100). (D) Prominent intralesional fibrotic bands, as well as a trabecular growth
pattern (40).

TABLE 3

Postoperative clinical findings.

The mean age of diagnosis in this study is similar to that previn

%

Recurrent laryngeal nerve paresis/
paralysis

4

14

Hungry bone syndrome

2

7

Recurrent disease

0a

0

ously reported for sporadic APT.2,3 Similarly, the APT female: male
ratio has been reported to be between 1:1 and 2:1, where parathyroid
carcinoma is typically 1:1 and benign adenomas are typically 4:1.3,8,11
Interestingly, there was no recurrence and only one case of persistent hypercalcemia on follow-up. This is distinct from parathyroid
carcinoma, in which the prevalence of persistent or recurrent disease

a

One patient with persistent hypercalcemia is currently under observation.
One death occurred unrelated to disease.

is up to 49%–60%, and more in line with single adenoma or multiple
gland hyperplasia, in which the recurrence rate is <1%.8,12 This is surprising considering the fibrotic nature of APTs relative to their benign

a high incidence of recurrent laryngeal nerve injury from parathyroid-

adenoma counterparts, it would be expected that incomplete re-

ectomy surgery.

section intraoperatively (and ensuing persistent disease) would be

Patients with APTs may be at increased risk for RLN injury due to

more common, but it falls in line with Christakis et al., who reported a

the fibrotic nature of the disease. Gross adherence to nearby struc-

recurrence rate of <5% in APT resection.2,13 Only 7% of patients in

tures was noted during many cases in this series, with specific RLN

this study experienced hungry bone disease post-parathyroidectomy.

adherence in 46% of the cases. Routine parathyroidectomy for PHPT

This is in line with the prevalence of hungry bone disease after para-

due to parathyroid adenoma typically experience clean planes during

thyroidectomy for adenomas causing PHPT in a case series from the

surgical dissection with relative ease of removal using simple blunt

1980s (13%); however, more recent data suggested a larger range

dissection in the majority of cases.6 However, because APTs have

from 4% to 82%.14

increased fibrosis and inflammation, we observed that the rate of RLN

This study continues to demonstrate the ambiguous nature of

adherence intraoperatively and injury postoperatively in this study

APTs. Some features were more similar to benign adenomas (recur-

(46% and 14%, respectively) to be much higher than published injury

rence rate), others to carcinoma (intraoperative fibrosis and adher-

rates of benign adenomas (<1%).7 Yet it still lower than that of para-

ence), and others fell in between (female: male ratio, RLN injury). In

thyroid carcinoma, which has been reported to be as high as 38%.8

2013, Kruiff et al. reported that negative parafibromin staining

Preoperatively, laboratory values and imaging can play an impor-

predicted malignant behavior in APTs.15 Given the spectrum of APT

tant role in anticipating a more difficult surgery from an APT. On labo-

behavior noted in this study, future studies should characterize how

ratory evaluation, APTs are characterized by elevated calcium and

various APT qualities (such as parafibromin staining) can help predict

PTH to levels similar to that of parathyroid carcinoma.3 Unfortunately,

postoperative outcomes. As expected, the main limitations of this

this study was limited by inability to access the preoperative PTH

study include retrospective nature and small sample size, due to the

and calcium data for all subjects. Compared to typical parathyroid ade-

rarity of APTs.

nomas, which appear hypoechoic on ultrasound, APTs more frequently have isoechoic or cystic components, similar to parathyroid
carcinoma.9,10 In reviewing our preoperative imaging, the APTs

5
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CONC LU SION

exhibited a variable appearance, with hypoechoic, cystic, and isodense
features in different patients, similar to the findings of previous stud-

Despite the new AJCC categorization of atypical tumors staged as

ies (Figure 2).

“Tis,” we observed no recurrence of disease after resection and no
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disease-specific mortality. However, patients with atypical tumors
may be at increased risk for RLN injury and incomplete resection intraoperatively given the fibrotic nature of the tumor. Addi-

8.

tional studies will be needed to explore the factors that may
predispose APTs to fibrosis and adherence to surrounding structures

9.

to allow surgeons to anticipate potential complications prior to
surgery.
10.
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